In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1532-72-5, name is Isoquinoline N-Oxide, introducing its new discovery. COA of Formula: C9H7NO
A process for the production of aromatic heterocyclic N-oxides by reaction between an aromatic compound comprising a heterocyclic nitrogen atom and hydrogen peroxide in the presence of a manganese porphyrin catalyst is provided. The manganese porphyrin catalyst is substituted by an aromatic group at each meso-position, the aromatic nuclei of the aromatic substituents being substituted by one or more electron-withdrawing groups and/or comprising an aromatic quaternary ammonium heteroatom in the aromatic ring. Preferably, the manganese porphyrin catalyst is manganese tetrakis (2,6-dichlorophenyl) porphyrin chloride, manganese tetrakis (2,6-dichlorophenyl-4-sulphonic acid) porphyrin chloride, manganese tetrakis (4-methylpyridinium) porphyrin chloride, or manganese tetrakis (pentafluorophenyl) porphyrin chloride.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1532-72-5, and how the biochemistry of the body works.COA of Formula: C9H7NO
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H394N – PubChem